查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1471075

感染控制市场：按感染、产品和最终用户划分 - 2024-2030 年全球预测

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年感染控制市场规模为436.2亿美元，预计2024年将达457.9亿美元，2030年将达到623.6亿美元，复合年增长率为5.23%。

感染控制是指防止感染疾病传播的严格方法和做法。这个多方面的学术领域涉及确定感染源、了解感染疾病传播的机制以及实施策略措施以减轻传染源的传播。科学、理论和实践相结合，保护医护人员、病人和公众免受传染病的风险。由于医院感染发生率上升、感染疾病爆发期间感染控制意识和需求不断提高、灭菌技术的进步、医疗基础设施的扩大以及有关感染预防措施的严格全球法规，感染控制市场有望强劲增长。市场开拓机会包括开发环保消毒方法、引入物联网和人工智慧进行卫生管理、进入医疗标准不断提高的新兴市场以及开发处理传染性废弃物的创新方法等解决方案。然而，诸如先进灭菌设备的高成本、低收入地区的认识和实践有限、医护人员因缺乏培训而抵制以及对感染性废弃物处理的环境问题等挑战仍然成为显着的障碍。为了实现持续成长，该产业专注于具有成本效益的灭菌技术、环保的一次性产品、自动化即时感染控制监测，并努力使感染控制解决方案更容易获得且负担得起，需要协作努力等技术创新。

主要市场统计
基准年[2023] 436.2亿美元
预测年份 [2024] 457.9亿美元
预测年份 [2030] 623.6亿美元
复合年增长率（%） 5.23%

为了确保製造的医疗设备的安全，使用灭菌来去除包括孢子在内的所有型态的微生物的方法正在迅速增加。

此类别包括旨在消除或减少表面、设备和皮肤上的有害病原体的产品。干洗手剂的配製是为了杀死或抑制人们手上的细菌生长。在医疗保健环境中，防止交叉污染和感染非常重要。器械消毒剂用于医疗器械灭菌消毒，降低感染传播风险。皮肤消毒剂是用于在医疗程序之前或接触污染物之后去除皮肤上的微生物的消毒剂。表面消毒剂是旨在对各种环境下的表面进行消毒的产品，有效降低传播感染的风险。消毒过程中使用的设备和机械提高了效率和效果。 Flasher 消毒器是一种自动化系统，用于对医疗设备和管道设备清洗和消毒，以防止微生物污染。超音波清洗透过超音波照射清洗液来去除污染物，对于精密仪器特别有效。紫外线消毒器可发射 UV-C 光来消灭细菌、病毒和真菌病原体，适用于对錶面、水和空气进行消毒。清洗消毒机在高温下有效运行，对医疗器材进行彻底清洗消毒。消毒剂的物理成分根据不同的应用和偏好而量身定制。消毒喷雾剂是液体製剂，可轻鬆涂布在表面或空气中，提供快速方便的消毒效果。消毒湿纸巾是浸有消毒剂溶液的湿纸巾，是快速清洁和消毒表面的理想选择。液体消毒剂可以直接涂布或稀释后用于各种消毒任务。消毒方法根据其杀菌活性程度进行分类，对于为各种应用选择合适的产品非常重要。高水平消毒可消灭除大量细菌孢子外的所有微生物。用于与无菌身体部位接触的物品。中等程度惰性病毒、细菌、真菌和分枝桿菌，但不一定会惰性大量细菌孢子。

低浓度可消除大多数细菌、部分病毒和真菌，但不会杀死分枝桿菌或孢子形成细菌，适用于非关键表面。内视镜再处理对于预防与内视镜使用相关的感染至关重要，需要特定的程序和产品来确保彻底消毒。消耗品包括专门用于清洗和消毒内视镜的清洁剂、擦拭巾和刷子。防护屏障是提供物理屏障并保护医护人员和病患免受感染源影响的设备或材料。盖子和封闭物旨在密封或覆盖设备或区域以防止污染。护目镜可以保护您的眼睛免受飞沫、喷雾剂和可能含有传染性物质的飞沫的侵害。医用不织布是医疗环境中用来防止交叉污染的一次性织物，例如罩衣、手术单和口罩。灭菌是医疗机构采用的过程，透过消除包括孢子在内的所有型态的微生物生命来确保医疗设备的安全。电子束灭菌利用电子束快速有效地对适合多种材料的医疗产品进行灭菌。器械灭菌使用蒸气、干热和化学物质等方法对医疗设备进行灭菌，以便可以安全地重复使用。 ETO灭菌使用环氧乙烷气体对医疗设备进行灭菌，对于对热和湿气敏感的材料有效。过滤灭菌透过过滤物理性去除微生物，适用于热敏性液体。伽玛灭菌利用伽玛射线穿透产品彻底灭菌，常用于一次性医疗设备。放射线杀菌包括伽马射线和电子束灭菌，并深入渗透到各种产品中。蒸气灭菌是一种广泛使用且有效的方法，利用加压蒸气来实现微生物惰性，对于耐热设备来说是理想的选择。

最终使用者：扩大医院和诊所感染控制的使用

在食品和饮料行业，感染控制包括透过严格的卫生管理和消毒来预防食物中毒。此细分市场需要针对多种病原体的有效解决方案，同时又能在食品加工环境中安全使用。成长机会在于创新的消毒技术和符合食品安全监管标准的环保消毒剂。医疗保健和诊所仍然处于感染控制的最前沿，因为预防医疗保健相关感染 (HAI) 至关重要。医院和诊所需要全面的解决方案，包括灭菌设备、消毒剂和服务，以确保患者照护的无菌环境。技术的进步和对病人安全标准的日益重视正在推动对高效产品和服务的需求。生命科学产业，包括研究机构和生物技术公司，需要采取严格的措施来确保研究和生产过程的完整性。生命科学产业需要能够无缝整合到业务中的创新灭菌和净化技术。我们专注于提供有效的解决方案，而不影响敏感材料或实验结果。对于医疗设备公司来说，感染控制对于医疗产品的设计、製造和使用至关重要。这就需要采用灭菌製程和涂层来防止设备受到微生物污染，尤其是那些涉及侵入性手术的设备。与感染控制专家合作，他们可以根据您的特定设备要求提供自订解决方案，这是一个策略机会。製药公司需要感染控制以确保其产品和无尘室环境的无菌性。製药公司对在製造过程中保持无菌和防止交叉污染的技术和服务感兴趣。这些公司通常在全球范围内运营，增加了对符合国际标准且扩充性的解决方案的需求。

区域洞察

在 CDC 和 FDA 等严格监管指南的推动下，美洲先进感染控制技术的采用率很高。该地区有多家公司进入感染控制市场，为全球产能做出了重大贡献。此外，我们也高度重视研究和创新，使感染控制方法持续进步。相反，亚太地区是该领域成长最快的地区。这是由于健康和卫生习惯意识的提高、医疗保健成本的上升以及医疗保健基础设施的扩张，特别是在中国和印度等国家。该地区的生产由国内和国际公司混合而成，并且正在努力扩大製造能力以满足不断增长的需求。欧洲、中东和非洲地区具有多样性，欧洲国家在医疗保健法规和高品质标准的推动下拥有完善的感染控制实践。中东和非洲地区面临医疗设施和技术不平等的挑战，但这些挑战正在缓慢改善。该地区是许多国内和国际公司的所在地，这些公司希望向服务不足的地区扩张，这展示了感染控制实践的成长潜力。

FPNV定位矩阵

FPNV定位矩阵对于评估感染控制市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对感染控制市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.感染控制市场的市场规模和预测是多少？

2.在感染控制市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3.感染控制市场的技术趋势和法规结构是什么？

4.感染控制市场主要厂商的市场占有率为何？

5. 进入感染控制市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医院感染发生率上升和感染控制产品的快速使用
      • 外科手术的增加和采取适当安全措施的必要性
      • 感染控制产品在医疗设备和製药业的快速采用
    • 抑制因素
      • 与化学消毒剂相关的副作用
    • 机会
      • 医院和诊所增加灭菌服务外包
      • 製造商增加感染控制产品生产的投资
    • 任务
      • 替代感染控制产品和技术的可用性
  • 市场区隔分析
    • 产品：灭菌的使用正在迅速增加，以通过去除包括孢子在内的所有型态的微生物来确保医疗设备的安全。
    • 最终使用者：不断发展医院和诊所部门感染控制的使用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 感染控制市场传播

  • 空气
  • 血源性的
  • 合约

第七章感染控制市场：副产品

  • 清洁消毒
  • 内视镜再处理
  • 防护屏障
  • 消毒

第八章感染控制市场：依最终用户分类

  • 食品和饮料公司
  • 医院/诊所
  • 生命科学产业
  • 医疗设备公司
  • 製药公司

第九章美洲感染控制市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太感染控制市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的感染控制市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 科德宝医疗在哥斯大黎加建立第二个生产工厂
    • WPT 非织造布公司在肯塔基州製造工厂投资 1,950 万美元，以促进当地经济
    • Berry 推出了轻型管封闭解决方案，符合感染控制通讯协定规定的严格安全和卫生标准。
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-43676CF42B0E

[195 Pages Report] The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices

Cleaning & disinfection are essential in preventing the spread of infection, this category includes products designed to eliminate or reduce harmful pathogens on surfaces, instruments, and skin. Hand Disinfectants are formulated to kill or inhibit the growth of germs on human hands. These are crucial in healthcare settings to prevent cross-contamination and infections. Instrument disinfectants are used for sterilizing and disinfecting medical instruments, reducing the risk of infection transmission. Skin disinfectants are antiseptic agents used to cleanse the skin of microbes before medical procedures or after exposure to contaminants. Surface disinfectants are products designed to sanitize surfaces in various environments, effectively reducing the risk of spreading infections. Devices and machines used in the disinfection process enhance efficiency and effectiveness. Flusher disinfectors are automated systems for the cleaning and Disinfection of medical devices and plumbing fixtures to prevent microbial contamination. Ultrasonic cleaners use ultrasonic waves in a cleaning solution to remove contaminants from items, which is particularly effective for delicate instruments. UV-Ray disinfectors that deploy UV-C light to destroy bacterial, viral, and fungal pathogens suitable for surface, water, and air disinfection. Washer disinfectors thoroughly clean and disinfect medical utensils, operating effectively at high temperatures. The physical composition of disinfection agents is tailored for various uses and preferences. Disinfectant sprays are liquid formulations designed for easy application on surfaces or air, offering quick and convenient Disinfection. Disinfectant wipes are pre-moistened towelettes impregnated with disinfectant solutions, ideal for quick cleanup and Disinfection of surfaces. Liquid disinfectants can be applied directly or diluted used for a broad range of disinfection tasks. Disinfection practices are categorized by the extent of microbicidal activity, which is important in selecting the appropriate products for various applications. High-Level Disinfection destroys all microorganisms, except large numbers of bacterial spores. Used for items that come in contact with sterile body areas. Intermediate-level inactivates viruses, bacteria, fungi, and mycobacteria, but not necessarily high numbers of bacterial spores.

Low-level eliminates most bacteria, some viruses, and fungi but does not kill mycobacteria or spores and is suitable for non-critical surfaces. Endoscope reprocessing is critical for preventing infections associated with endoscope use, involving specific steps and products to ensure thorough Disinfection. Consumables include detergents, wipes, and brushes specifically designed for cleaning and disinfecting endoscopes. Protective Barriers are quipment and materials that provide a physical barrier, protecting healthcare workers and patients from infectious agents. Covers & closures are designed to seal or cover equipment and areas to prevent contamination. Goggles protect eyes from splashes, sprays, and droplets that may contain infectious agents. Medical nonwovens are disposable fabrics used in medical settings to prevent cross-contamination, including gowns, drapes, and masks. Sterilization is the process that eliminates all forms of microbial life, including spores, employed in healthcare facilities to ensure the safety of medical devices. E-Beam sterilization utilizes electron beams to sterilize medical products quickly and effectively, suitable for various materials. Equipment sterilization involves methods such as steam, dry heat, and chemicals to sterilize medical equipment, ensuring its safe reuse. ETO sterilization uses ethylene oxide gas to sterilize medical devices, effective for materials sensitive to heat and moisture. Filtration sterilization employs physical removal of microorganisms through a filtration membrane, suitable for heat-sensitive liquids. Gamma sterilization relies on gamma rays to penetrate and sterilize products thoroughly, commonly used for single-use medical devices. Radiation sterilization encompasses gamma and e-beam sterilization, offering deep penetration for various products. Steam sterilization is a widely used, effective method utilizing pressurized steam to achieve microbial inactivation, ideal for heat-resistant devices.

End-User: Evolving usage of infection control in hospitals & clinics sector

In the food and beverage sector, infection control prevents foodborne illnesses through stringent hygiene and sanitization practices. This market segment demands effective solutions against a broad spectrum of pathogens yet safe for use in food processing environments. Growth opportunities lie in innovative disinfection technologies and eco-friendly sanitizers that meet regulatory standards for food safety. Hospitals and clinics remain at the forefront of infection control due to the critical need to prevent healthcare-associated infections (HAIs). Hospitals and clinics require comprehensive solutions, including sterilization equipment, disinfectants, and services that ensure a sterile environment for patient care. Advances in technology and increased emphasis on patient safety standards drive demand for high-efficiency products and services. The life sciences industry, encompassing research laboratories and biotech companies, necessitates stringent infection control measures to ensure the integrity of research and production processes. The life sciences industry seeks innovative sterilization and decontamination technologies that seamlessly integrate into their operations. The focus is on effective solutions without compromising sensitive materials or experimental outcomes. For medical device companies, infection control is pivotal in medical product design, manufacture, and usage. The demand here is for sterilization processes and coatings that prevent microbial contamination of devices, particularly those involved in invasive procedures. Partnering with infection control specialists who can offer custom solutions tailored to specific device requirements represents a strategic opportunity. Pharmaceutical companies need infection control to ensure the sterility of products and the cleanroom environments in which they are produced. Pharmaceutical companies are interested in technologies and services that maintain aseptic conditions and prevent cross-contamination during manufacturing. As these companies often operate globally, there is a growing demand for compliance with international standards and scalable solutions.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Transmission
    • Airborne
    • Bloodborne
    • Contract
  • Products
    • Cleaning & Disinfection
      • Disinfectants
        • Hand Disinfectants
        • Instrument Disinfectants
        • Skin Disinfectants
        • Surface Disinfectants
      • Equipment
        • Flusher Disinfectors
        • Ultrasonic Cleaners
        • UV-Ray Disinfectors
        • Washer Disinfectors
      • Formulation
        • Disinfectant Sprays
        • Disinfectant Wipes
        • Liquid Disinfectants
      • Level of Disinfection
        • High-Level
        • Intermediate-Level
        • Low-Level
    • Endoscope Reprocessing
      • Consumables
      • Equipment
    • Protective Barriers
      • Covers & Closures
      • Goggles
      • Medical Nonwovens
    • Sterilization
      • E-Beam Sterilization
      • Equipment Sterilization
      • ETO Sterilization
      • Filtration Sterilization
      • Gamma Sterilization
      • Radiation Sterilization
      • Steam Sterilization
  • End-User
    • Food & Beverage Companies
    • Hospitals & Clinics
    • Life Sciences Industry
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Infection Control Market?

4. What is the market share of the leading vendors in the Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Infection Control Market?

[195 Pages Report] The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices

Cleaning & disinfection are essential in preventing the spread of infection, this category includes products designed to eliminate or reduce harmful pathogens on surfaces, instruments, and skin. Hand Disinfectants are formulated to kill or inhibit the growth of germs on human hands. These are crucial in healthcare settings to prevent cross-contamination and infections. Instrument disinfectants are used for sterilizing and disinfecting medical instruments, reducing the risk of infection transmission. Skin disinfectants are antiseptic agents used to cleanse the skin of microbes before medical procedures or after exposure to contaminants. Surface disinfectants are products designed to sanitize surfaces in various environments, effectively reducing the risk of spreading infections. Devices and machines used in the disinfection process enhance efficiency and effectiveness. Flusher disinfectors are automated systems for the cleaning and Disinfection of medical devices and plumbing fixtures to prevent microbial contamination. Ultrasonic cleaners use ultrasonic waves in a cleaning solution to remove contaminants from items, which is particularly effective for delicate instruments. UV-Ray disinfectors that deploy UV-C light to destroy bacterial, viral, and fungal pathogens suitable for surface, water, and air disinfection. Washer disinfectors thoroughly clean and disinfect medical utensils, operating effectively at high temperatures. The physical composition of disinfection agents is tailored for various uses and preferences. Disinfectant sprays are liquid formulations designed for easy application on surfaces or air, offering quick and convenient Disinfection. Disinfectant wipes are pre-moistened towelettes impregnated with disinfectant solutions, ideal for quick cleanup and Disinfection of surfaces. Liquid disinfectants can be applied directly or diluted used for a broad range of disinfection tasks. Disinfection practices are categorized by the extent of microbicidal activity, which is important in selecting the appropriate products for various applications. High-Level Disinfection destroys all microorganisms, except large numbers of bacterial spores. Used for items that come in contact with sterile body areas. Intermediate-level inactivates viruses, bacteria, fungi, and mycobacteria, but not necessarily high numbers of bacterial spores. Low-level eliminates most bacteria, some viruses, and fungi but does not kill mycobacteria or spores and is suitable for non-critical surfaces. Endoscope reprocessing is critical for preventing infections associated with endoscope use, involving specific steps and products to ensure thorough Disinfection. Consumables include detergents, wipes, and brushes specifically designed for cleaning and disinfecting endoscopes. Protective Barriers are quipment and materials that provide a physical barrier, protecting healthcare workers and patients from infectious agents. Covers & closures are designed to seal or cover equipment and areas to prevent contamination. Goggles protect eyes from splashes, sprays, and droplets that may contain infectious agents. Medical nonwovens are disposable fabrics used in medical settings to prevent cross-contamination, including gowns, drapes, and masks. Sterilization is the process that eliminates all forms of microbial life, including spores, employed in healthcare facilities to ensure the safety of medical devices. E-Beam sterilization utilizes electron beams to sterilize medical products quickly and effectively, suitable for various materials. Equipment sterilization involves methods such as steam, dry heat, and chemicals to sterilize medical equipment, ensuring its safe reuse. ETO sterilization uses ethylene oxide gas to sterilize medical devices, effective for materials sensitive to heat and moisture. Filtration sterilization employs physical removal of microorganisms through a filtration membrane, suitable for heat-sensitive liquids. Gamma sterilization relies on gamma rays to penetrate and sterilize products thoroughly, commonly used for single-use medical devices. Radiation sterilization encompasses gamma and e-beam sterilization, offering deep penetration for various products. Steam sterilization is a widely used, effective method utilizing pressurized steam to achieve microbial inactivation, ideal for heat-resistant devices.

End-User: Evolving usage of infection control in hospitals & clinics sector

In the food and beverage sector, infection control prevents foodborne illnesses through stringent hygiene and sanitization practices. This market segment demands effective solutions against a broad spectrum of pathogens yet safe for use in food processing environments. Growth opportunities lie in innovative disinfection technologies and eco-friendly sanitizers that meet regulatory standards for food safety. Hospitals and clinics remain at the forefront of infection control due to the critical need to prevent healthcare-associated infections (HAIs). Hospitals and clinics require comprehensive solutions, including sterilization equipment, disinfectants, and services that ensure a sterile environment for patient care. Advances in technology and increased emphasis on patient safety standards drive demand for high-efficiency products and services. The life sciences industry, encompassing research laboratories and biotech companies, necessitates stringent infection control measures to ensure the integrity of research and production processes. The life sciences industry seeks innovative sterilization and decontamination technologies that seamlessly integrate into their operations. The focus is on effective solutions without compromising sensitive materials or experimental outcomes. For medical device companies, infection control is pivotal in medical product design, manufacture, and usage. The demand here is for sterilization processes and coatings that prevent microbial contamination of devices, particularly those involved in invasive procedures. Partnering with infection control specialists who can offer custom solutions tailored to specific device requirements represents a strategic opportunity. Pharmaceutical companies need infection control to ensure the sterility of products and the cleanroom environments in which they are produced. Pharmaceutical companies are interested in technologies and services that maintain aseptic conditions and prevent cross-contamination during manufacturing. As these companies often operate globally, there is a growing demand for compliance with international standards and scalable solutions.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Transmission
    • Airborne
    • Bloodborne
    • Contract
  • Products
    • Cleaning & Disinfection
      • Disinfectants
        • Hand Disinfectants
        • Instrument Disinfectants
        • Skin Disinfectants
        • Surface Disinfectants
      • Equipment
        • Flusher Disinfectors
        • Ultrasonic Cleaners
        • UV-Ray Disinfectors
        • Washer Disinfectors
      • Formulation
        • Disinfectant Sprays
        • Disinfectant Wipes
        • Liquid Disinfectants
      • Level of Disinfection
        • High-Level
        • Intermediate-Level
        • Low-Level
    • Endoscope Reprocessing
      • Consumables
      • Equipment
    • Protective Barriers
      • Covers & Closures
      • Goggles
      • Medical Nonwovens
    • Sterilization
      • E-Beam Sterilization
      • Equipment Sterilization
      • ETO Sterilization
      • Filtration Sterilization
      • Gamma Sterilization
      • Radiation Sterilization
      • Steam Sterilization
  • End-User
    • Food & Beverage Companies
    • Hospitals & Clinics
    • Life Sciences Industry
    • Medical Device Companies
    • Pharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Infection Control Market?

4. What is the market share of the leading vendors in the Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Infection Control Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
      • 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
      • 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with chemical based disinfectants
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
      • 5.1.3.2. Growing investments by manufacturers in the production of infection control products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitute products and techniques for infection control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
    • 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Infection Control Market, by Transmission

  • 6.1. Introduction
  • 6.2. Airborne
  • 6.3. Bloodborne
  • 6.4. Contract

7. Infection Control Market, by Products

  • 7.1. Introduction
  • 7.2. Cleaning & Disinfection
  • 7.3. Endoscope Reprocessing
  • 7.4. Protective Barriers
  • 7.5. Sterilization

8. Infection Control Market, by End-User

  • 8.1. Introduction
  • 8.2. Food & Beverage Companies
  • 8.3. Hospitals & Clinics
  • 8.4. Life Sciences Industry
  • 8.5. Medical Device Companies
  • 8.6. Pharmaceutical Companies

9. Americas Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
    • 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
    • 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INFECTION CONTROL MARKET DYNAMICS
  • FIGURE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 106. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 107. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 108. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 109. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 110. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 111. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 112. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 113. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 114. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 115. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 116. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 117. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 118. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 119. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 120. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 121. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 122. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 123. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 124. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 125. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 126. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 127. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 128. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 129. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 130. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 131. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 132. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 133. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 136. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 137. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 138. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 139. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 140. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 141. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 142. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 143. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 144. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 145. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 146. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 147. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 148. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 149. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 150. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 151. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 152. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 153. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 154. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 155. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 156. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 157. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 160. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 161. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 162. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 163. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 164. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 165. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 166. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 167. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 168. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 169. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 170. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 171. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 172. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 173. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 174. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 175. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 176. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 177. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 178. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 179. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 182. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 183. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 184. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 185. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 186. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 187. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 188. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 189. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 190. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 191. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 194. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 195. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 196. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 197. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 198. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 199. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 200. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 201. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 204. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 205. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 206. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 207. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 208. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 209. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 210. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 211. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 212. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 213. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 214. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 215. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 216. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 217. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 218. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 219. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 220. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 221. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 222. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 223. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 226. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 227. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 228. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 229. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 230. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 231. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 232. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 233. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 234. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 235. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 236. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 237. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 238. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 239. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 240. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 241. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 242. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 243. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 244. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 245. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 248. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 273. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 274. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 275. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 276. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 277. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 278. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 279. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 280. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 281. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 282. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 283. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 284. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 285. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 286. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 287. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 288. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 289. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 290. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 291. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 292. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 293. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 296. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 297. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 298. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 299. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 300. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 301. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 302. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 303. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 304. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 305. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 306. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 307. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 308. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 309. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 310. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 311. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 312. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 313. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 314. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 315. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 318. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
  • TABLE 319. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 320. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 321. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 322. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 323. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
  • TABLE 324. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
  • TABLE 325. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 326. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 327. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 328. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 329. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
  • TABLE 330. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
  • TABLE 331. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
  • TABLE 332. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
  • TABLE 333. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
  • TABLE 334. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
  • TABLE 335. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
  • TABLE 336. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
  • TABLE 337. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
  • TABLE 340. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MIL